Rani Therapeutics Holdings (RANI) Invested Capital (2020 - 2025)

Rani Therapeutics Holdings' Invested Capital history runs 6 years deep, the most recent figure standing at $13.5 million for Q3 2025.

• In Q3 2025, Invested Capital fell 8.34% year-over-year to $13.5 million; the TTM figure through Mar 2026 stood at $28.5 million (down 49.99% YoY), while the FY2024 annual figure was $15.0 million, up 206.31% from the prior year.
• Invested Capital for Q3 2025 stood at $13.5 million, down from $15.0 million in the prior quarter.
• The five-year high for Invested Capital was $15.0 million in Q4 2024, with the low at $30000.0 in Q2 2022.
• The 5-year median for Invested Capital is $4.9 million (2023), against an average of $7.0 million.
• The sharpest annual moves came in 2022 and 2023: Invested Capital tumbled 99.23% in 2022, then jumped 2121.82% in 2023.
• Rani Therapeutics Holdings' Invested Capital stood at $126000.0 in 2021, then sank by 56.35% to $55000.0 in 2022, then surged by 8803.64% to $4.9 million in 2023, then surged by 206.31% to $15.0 million in 2024, then decreased by 9.75% to $13.5 million in 2025.
• Business Quant data shows RANI's Invested Capital at $13.5 million in Q3 2025, $15.0 million in Q2 2025, and $15.0 million in Q1 2025.